Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice

Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products

(2022) Mohamed Ibrahim et al.   JOURNAL OF CONTROLLED RELEASE

Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice

(2021) Sherif E. Emam et al.   JOURNAL OF CONTROLLED RELEASE

Derma roller mediated transdermal delivery of tizanidine invasomes for the management of skeletal muscle spasms

(2021) Leonna Dsouza et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement

(2021) Mariona Estapé Senti et al.   JOURNAL OF CONTROLLED RELEASE

Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice

(2020) Nehal E. Elsadek et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice

(2020) Nehal E. Elsadek et al.   MOLECULAR PHARMACEUTICS

Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect

(2019) Kamel S. Ahmed et al.   Materials Science & Engineering C-Materials for Biological Applications

Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications

(2016) Anisha A. D’souza et al.   Expert Opinion on Drug Delivery

The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?

(2016) Christian Lubich et al.   PHARMACEUTICAL RESEARCH

Synergistic efficacy of salicylic acid with a penetration enhancer on human skin monitored by OCT and diffuse reflectance spectroscopy

(2016) Qingliang Zhao et al.   Scientific Reports

Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein

(2015) Yu Mima et al.   MOLECULAR PHARMACEUTICS

Anti-PEG immunity: emergence, characteristics, and unaddressed questions

(2015) Qi Yang et al.   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Effects of Oils and Emulsifiers on the Skin Penetration of Stearyl Glycyrrhetinate in Oil-in-Water Emulsions

(2014) Osamu Sakata et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin

(2014) Takuya Suzuki et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs

(2014) Yosuke Hashimoto et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients

(2014) Michael S Hershfield et al.   ARTHRITIS RESEARCH & THERAPY

Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response

(2012) Taro Shimizu et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents

(2012) Ricardo P Garay et al.   Expert Opinion on Drug Delivery

Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs

(2012) Takuya Suzuki et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Polymers for Drug Delivery Systems

(2010) William B. Liechty et al.   Annual Review of Chemical and Biomolecular Engineering

PEG-modified biopharmaceuticals

(2009) Pascal Bailon et al.   Expert Opinion on Drug Delivery

Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles

(2009) Tsutomu Ishihara et al.   PHARMACEUTICAL RESEARCH

Particle size-dependent triggering of accelerated blood clearance phenomenon

(2008) Hiroyuki Koide et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS